Jeffrey W. Sherman - 21 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP and Chief Medical Officer
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 21 Jan 2022
Net transactions value: -$204,988
Form type: 4
Filing time: 24 Jan 2022, 16:05:28 UTC
Previous filing: 06 Jan 2022
Next filing: 21 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$0	+5,354	+9.5%	$0.000000	61,665	21 Jan 2022	Direct
transaction	HZNP	Ordinary Shares	Tax liability	$204,988	-2,372	-3.8%	$86.42	59,293	21 Jan 2022	Direct
holding	HZNP	Ordinary Shares						105,808	21 Jan 2022	See footnote	F1
holding	HZNP	Ordinary Shares						66,730	21 Jan 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units (RSUs)	Options Exercise	$0	-5,354	-100%	$0.000000^*	0	21 Jan 2022	Ordinary Shares	5,354		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
F2	Each RSU represents a contingent right to receive one ordinary share of the Issuer.